Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Scott McNairy


Scott McNairy

University of Minnesota, USA

Biography

Scott has 38 years experience in the delivery of clinical health care focused on treatment for chronic pain, addictive and combat stress disorders.  He is Board Certified in the Addiction Psychiatry. His post-graduate training in psychiatric medicine began at the Mayo Clinic 1975-1979. He is most indebted to early Mayo consultants for pioneering novel addiction and pain medicine treatment practices which serve as a foundation for his practice at the VA medical center Minneapolis.

He has had a lifelong interest in using evidence-based psychopharmacology, blended with alternative and complementary treatment approaches. Scott was an early board member for Minneapolis Pathways, one of the first health crisis resource centers for life-threatening medical illness in the country. Many of those practices are now well–integrated in to treatment for cancer and end of life care.

He champions greater use of addiction pharmacotherapy in primary care and psychiatry and trains physicians for the DEA buprenorphine waivered licensure. Another current interest is the utilization of pharmacy data mining for monitoring treatment outcomes that will enhance patient safety and care.

His clinical outcome studies have included 1) development of a medication management support group for opioid dependent patients treated with buprenorphine to promote treatment success and 2) the use of parenteral depot naltrexone for high medical risk, chronic and treatment refractory alcohol dependent veterans which dramatically reduces overall costs of care and disease progression.

At the University of Minnesota - VA campus he directs the fellowship in addiction psychiatry and site directs the ABAM addiction medicine fellowship newly recognized by ABMS and the Board of Preventive Medicine. He is recognized for his excellence in teaching and modeling positive clinical encounters. He places primary emphasis on restoration of function and prevention of deterioration as outcomes for success. Scott is an integral part of a treatment team comprised of physicians, nurses, social workers and psychologists without whom he could not have achieved the success that he has had

Abstract

Abstract : Efficacy of Injectable Extended-Release Naltrexone for Severe and Chronic Relapsing Alcohol Use Disorders